This edition of the Life Science, Health & Wellness Technology Opportunity Engine (TOE) provides analytics across recent developments for intelligent drug discovery solutions, precision oncology and novel biologics. It also comprises innovations across stem cell therapies and radiotherapies. It features disruptive technological advances in the global life sciences industry.

• What are the technological advancements across the microbiome, biomarkers, and synthetic biology industries?
• Which significant innovations are impacting disease management and drug discovery & development?
• How can you harness game-changing growth prospects redefining the future of genetic engineering and tissue engineering?